| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4b8c63abff709ab6e02e90f23ae6920 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ee3186beff60cdcc244e8fc9f977faa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd26b321e098808c1abefa5f0cb7db13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab0ac986552e6a9c8559c9a702b7f067 |
| publicationDate |
2022-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220044874-A |
| titleOfInvention |
Methods for treating alzheimer's disease |
| abstract |
A method of treating a human patient with Alzheimer's disease (AD) comprises sequentially administering to the patient multiple doses of a recombinant fully human anti-amyloid beta monoclonal antibody. In a preferred embodiment, the antibody is administered in incremental doses over time. In a preferred embodiment, the patient's vulnerability to amyloid-associated imaging abnormalities (ARIA) is thereby reduced. |
| priorityDate |
2014-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |